Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510857 · ClinicalTrials.gov registry record · NA
Motivating Occupational Virtual Experiences In Therapy for Kids
A NA study, sponsored by Barron Associates.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04510857: Completed NA study, sponsored by Barron Associates.
NCT04510857 is a NA study that has completed, run by Barron Associates. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04510857, a NA study, has completed, sponsored by Barron Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
A rater-blinded randomized controlled trial (RCT) will be conducted to compare the efficacy of MOVE-IT use in a remotely supervised home exercise program (HEP) to usual care for recovery of upper extremity (UE) function in children with hemiplegia.
Primary Outcome
The JTHFT assesses hand function through timed movements such as simulated page turning, eating, stacking objects, and lifting objects of different size and mass. The JTHFT total score is simply the sum of all timed movements (in seconds). A lower score represents a better outcome.
Interventions
- DEVICE MOVE-IT Intervention
- BEHAVIORAL UCT Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2024-06-15 |
| Phase | NA |
What the finished NCT04510857 record still lists
NCT04510857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which MOVE-IT Intervention is the first listed.
NCT04510857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04510857 about?
NCT04510857 is a clinical study titled "Motivating Occupational Virtual Experiences In Therapy for Kids". A rater-blinded randomized controlled trial (RCT) will be conducted to compare the efficacy of MOVE-IT use in a remotely supervised home exercise program (HEP) to usual care for recovery of upper extremity (UE) function in children with hemiplegia.
What is the current status of trial NCT04510857?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-06-17. Estimated completion is 2024-06-15.
What interventions are being tested in trial NCT04510857?
The interventions under investigation include: MOVE-IT Intervention (DEVICE), UCT Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT04510857?
This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04510857's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI